Trial Profile

Phase 1 trial of APD-418 for Decompensated heart failure

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs APD 418 (Primary)
Indications Decompensated heart failure
Focus Adverse reactions; First in man
Sponsors Arena Pharmaceuticals

Most Recent Events

09 Nov 2020 Status changed from recruiting to completed, according to an Arena Pharmaceuticals media release.
05 Aug 2020 Status changed from suspended to recruiting.
05 Aug 2020 According to an Arena Pharmaceuticals media release, this trial has resumed

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com